SÃO PAULO, August 8, 2026, 18:09 BRT
Ambev S.A. (NYSE:ABEV; BVMF:ABEV3) finished a week of losses, even as cash conversion improved significantly. The company’s U.S. shares settled at $3.00 on Friday, marking a 3.5% decline from July 31. Markets in New York and São Paulo did not open on Saturday.
The difference is significant. In the second quarter, operating cash flow was 135% of normalized profit, compared to 108% in the same period last year. However, just two out of five business units reported volume growth.
That combination clarifies Ambev’s upcoming challenge. Cash flow has strengthened, though its core demand remains limited. Increased activity during the World Cup also supported its top-performing unit.
Latest analyst figures highlight ongoing caution. Among a group of three analysts, none have issued buy ratings, and the consensus price target is $3.20 on average. This suggests a potential upside of just 6.7% compared to Friday’s closing price.
| Market instrument | August 7 close | Friday | Week |
|---|---|---|---|
| Ambev ADR | $3.00 | -0.33% | -3.54% |
| Ambev ordinary shares | R$15.48 | -1.15% | -3.19% |
| Ibovespa | 172,513.42 | -1.73% | -3.08% |
Weekly shifts are measured from close on July 31 to close on August 7. Dividend payments are not included in price returns.
The ADR underperformed the Ibovespa by approximately 0.5 percentage point last week. On Friday, volume totaled 37.8 million shares, which is about 33% higher than its 65-day average. The session saw brisk trading.
| Second-quarter measure | 2026 | 2025 | Change |
|---|---|---|---|
| Operating cash flow | R$4.711 billion | R$3.050 billion | Up 54.5% |
| Normalized profit | R$3.493 billion | R$2.833 billion | Up 23.3% |
| Cash flow/profit conversion | 134.9% | 107.7% | Increase of 27.2 percentage points |
| Normalized EBITDA margin | 31.6% | 30.6% | Rise of 100 basis points reported |
Ambev’s reported data used for conversion ratios. The company recorded organic EBITDA-margin growth of 80 basis points.
Robust cash quality provided the main offset. Operating cash flow increased at more than double the pace of profit. Enhanced working-capital management contributed to the gain.
Chief Executive Carlos Lisboa stated that the strategy resulted in “another quarter of beer volume growth” along with strong performance at both the top and bottom line. Normalized EBITDA rose 8.9%, and the margin climbed to 31.6%.
Nevertheless, revenue came in below forecasts. At R$20.15 billion, it was 3.3% lower than the consensus estimate of R$20.83 billion. This shortfall could be a reason why robust cash generation has yet to drive a rerating.
| Business unit | Organic volume | Organic net revenue |
|---|---|---|
| Central America and Caribbean | up 5.4% | rose 7.1% |
| Brazil beer | higher by 5.0% | increased 8.9% |
| Canada | down 1.8% | up 2.1% |
| Latin America South | fell 2.9% | advanced 4.4% |
| Brazil non-alcoholic beverages | dropped 4.4% | gained 1.4% |
Revenue rose across all five units, though just two saw higher volumes.
Much of the quarter’s performance was driven by pricing and product mix. Organically, consolidated net revenue per hectoliter increased by 4.6%, helping to counter declines in physical sales in most divisions.
Beer sales in Brazil continued to drive results, with volume up 5.0%, revenue rising 8.9%, and normalized EBITDA increasing 12.8%. The company pointed to stronger market share, a recovering sector, and additional demand from the World Cup.
In Brazil, non-alcoholic beverages reported a contrasting trend. Volumes declined by 4.4%, while EBITDA rose 13.8%. Margin grew by 320 basis points as gains in revenue and efficient cost control balanced out softer demand.
Premium beer volumes rose in the high teens, while no-alcohol beer advanced by the low twenties. Michelob Ultra’s volume in Brazil and Argentina more than tripled during the quarter.
Capital returns offer further support. By July 30, Ambev had distributed nearly R$5.9 billion to its shareholders this year. The company had completed about 95% of its buyback and authorized a fresh R$1.1 billion distribution via interest-on-capital.
| Recommendation sample | Bullish | Neutral | Bearish | Average target | Upside from $3.00 |
|---|---|---|---|---|---|
| Last three-month sample | 0 | 2 | 1 | $3.20 | 6.7% |
| Wider current sample | 4 | 10 | 5 | $3.23 | 7.7% |
| Company-released coverage list | 4 | 11 | 3 | Not published | — |
The wide-ranging sample groups label “overweight” as bullish recommendations and “underweight” as bearish recommendations. Because the coverage intervals and approaches vary, direct comparison between rows is not possible. Google
Neutral ratings are the most common among the datasets. On average, price targets imply gains of under 8% from Friday’s closing value. Both samples indicate there is little margin in valuations.
Brazil is set to publish July inflation data on Tuesday next week. June services figures will be released on Wednesday, and June retail sales arrive Thursday. These updates will be closely watched after the central bank lowered the Selic rate to 14.00% on August 5. Ambev’s upcoming quarterly results are scheduled for October 29.
Risks: Demand from the World Cup could taper off, with Brazil’s non-alcoholic sales still sluggish. Elevated interest rates may continue to limit consumer spending. Ambev maintains its projection that Brazil beer cash costs per hectoliter will rise by 4.5% to 7.5% this year.
The key for investors is breadth rather than available cash. A more extensive volume recovery would confirm the improved conversion and support the rerating argument. Currently, the prevailing view among analysts is still Hold.
Related articles: NYSE:ABEV
